{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:47:22Z","timestamp":1762854442302,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.gofs.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T01:35:52Z","timestamp":1642901752000},"page":"497-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibiteurs de l\u2019enzyme de conversion et n\u00e9phrom\u00e9galie f\u0153tale"],"prefix":"10.1016","volume":"50","author":[{"given":"C.","family":"Michel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2022.01.001_bib0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.earlhumdev.2005.11.001","article-title":"Fetopathy associated with exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists","volume":"82","author":"Quan","year":"2006","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.gofs.2022.01.001_bib0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.gofs.2022.01.001_bib0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1523-1755.2000.00167.x","article-title":"Fetal serum beta2-microglobulin predicts postnatal renal function in bilateral uropathies","volume":"58","author":"Dommergues","year":"2000","journal-title":"Kidney Int"},{"issue":"Suppl. 2","key":"10.1016\/j.gofs.2022.01.001_bib0075","doi-asserted-by":"crossref","first-page":"SP251","DOI":"10.2131\/jts.34.SP251","article-title":"Children's toxicology from bench to bed\u00a0\u2013\u00a0Drug-induced renal injury (2): nephrotoxicity induced by cisplatin and ifosfamide in children","volume":"34","author":"Fujieda","year":"2009","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.gofs.2022.01.001_bib0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.earlhumdev.2005.11.001","article-title":"Fetopathy associated with exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists","volume":"82","author":"Quan","year":"2006","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.gofs.2022.01.001_bib0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.jp.7210766","article-title":"Pregnancy with prolonged fetal exposure to an angiotensin-converting enzyme inhibitor","volume":"22","author":"Muller","year":"2002","journal-title":"J Perinatol"},{"key":"10.1016\/j.gofs.2022.01.001_bib0090","unstructured":"Masson E. Diagnostic ant\u00e9natal des uropathies malformatives. EM-Consulte n.d. https:\/\/www.em-consulte.com\/article\/50075\/diagnostic-antenatal-des-uropathies-malformatives [accessed October 18, 2020]."},{"key":"10.1016\/j.gofs.2022.01.001_bib0095","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00467-013-2749-4","article-title":"Fetal renin-angiotensin-system blockade syndrome: renal lesions","volume":"29","author":"Plazanet","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.gofs.2022.01.001_bib0100","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1681\/ASN.V391575","article-title":"Angiotensin-converting enzyme inhibitor fetopathy","volume":"3","author":"Pryde","year":"1993","journal-title":"JASN"},{"key":"10.1016\/j.gofs.2022.01.001_bib0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/14767050500072862","article-title":"Fatal neonatal renal failure due to maternal enalapril ingestion","volume":"17","author":"Murki","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.gofs.2022.01.001_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/HJH.0000000000002233","article-title":"Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study","volume":"38","author":"Weber-Schoendorfer","year":"2020","journal-title":"J Hypertens"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718922000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718922000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:42:29Z","timestamp":1762854149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718922000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2468718922000034"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2022.01.001","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiteurs de l\u2019enzyme de conversion et n\u00e9phrom\u00e9galie f\u0153tale","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}